Hydroxylation, catalyzed by enzymes such as prolyl hydroxylases, plays a role in stabilizing hypoxia-inducible factor-1 alpha (HIF-1α), which promotes tumor adaptation to hypoxic conditions [79,80]. The gene discussed is HIF1A; the disease is neoplasm.